News
B of A Securities Maintains Buy on Royalty Pharma, Lowers Price Target to $38
12 Apr 24
News, Price Target, Analyst Ratings
Looking Into Royalty Pharma's Recent Short Interest
4 Apr 24
Short Sellers, Short Ideas, Trading Ideas
Royalty Pharma Q4 Sales $596.00M Miss $673.65M Estimate, Net Income Attributable To Royalty Pharma $494M Versus Loss Of $(456)M Year Ago
15 Feb 24
Earnings, News
Earnings Scheduled For February 15, 2024
15 Feb 24
Earnings
Royalty Pharma's Earnings: A Preview
14 Feb 24
Earnings
Press releases
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
19 Apr 24
News, Press Releases
Treatment AI (CSE: TRUE) Unveils New AI-Powered Solutions Revolutionizing Medical Education
18 Apr 24
News, Press Releases
Royalty Pharma Declares Second Quarter 2024 Dividend
17 Apr 24
News, Dividends, Press Releases
Unleashing AI in Healthcare: The Game-Changing Partnership Between Treatment AI (CSE: TRUE) and aiXplain concurrent with Federal Momentum
16 Apr 24
News, Press Releases
AI Transforms Healthcare Stocks in 2024: Revolutionizing Medicine Across the Globe
11 Apr 24
News, Press Releases
Canada's Strategic Move Towards AI: An Investor and Trader's Perspective
9 Apr 24
News, Press Releases
Emerging AI Healthcare Pioneers Promise Medical Breakthroughs and Investment Opportunities (CSE: TRUE)
5 Apr 24
News, Press Releases
Royalty Pharma Reports Q4 and Full Year 2023 Results
15 Feb 24
Earnings, Press Releases
Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024
30 Jan 24
Press Releases